BUSINESS● LOWJul 24 · Jul 24, 2026, 4:59 PM
Lisata Therapeutics plunges after sale to Kuva Labs terminated
Seeking Alpha Tech
Lisata Therapeutics' stock has plunged following the termination of its sale to Kuva Labs. This event indicates a significant change in the company's financial outlook and corporate strategy.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Business
BUSINESSnowMunicipal Securities Underwriters Pay a Total of $325,000 in FinesSECBUSINESSnowSEC CHAIRMAN ARTHUR LEVITT, IOWA OFFICIALS TO HOLD INVESTORS’ TOWN MEETING IN DES MOINESSECBUSINESS44m agoCan India turn retrofitment into the next mobility revolution?The HinduBUSINESS1h agoChina’s nightmare: becoming the next JapanFinancial Times